Improved prognosis with induction chemotherapy in pathological complete responders after trimodality treatment for esophageal squamous cell carcinoma: Hypothesis generating for adjuvant treatment

医学 队列 病态的 肿瘤科 胃肠病学 内科学 置信区间 食管切除术 诱导化疗 食管鳞状细胞癌 化疗 佐剂 食管癌 放化疗 外科 癌症
作者
Shao-Lun Lu,Feng‐Ming Hsu,Chiao‐Ling Tsai,Jang‐Ming Lee,Pei‐Ming Huang,Chih‐Hung Hsu,Chia‐Chi Lin,Yih‐Leong Chang,Min‐Shu Hsieh,Jason Chia‐Hsien Cheng
出处
期刊:Ejso [Elsevier BV]
卷期号:45 (8): 1498-1504 被引量:14
标识
DOI:10.1016/j.ejso.2019.03.020
摘要

Abstract Purpose To compare the locations of recurrences and survival outcomes in esophageal squamous cell carcinoma (ESCC) patients with pathological complete response (pCR) after neoadjuvant concurrent chemoradiotherapy (CCRT) with or without preceding induction chemotherapy (IC) followed by esophagectomy. Methods Among 276 patients with locally advanced ESCC undergoing trimodality treatment during 2004–2014, 94 (34.1%) with pCR were eligible. The cohort included 26 patients undergoing IC before CCRT (IC group), and 68 patients who did not receive IC (non-IC group). Results At a median follow-up of 51.4 months (95% confidence interval; 42.9–62.1), 19 patients experienced recurrences. There was a trend toward fewer distant failures in the IC group (0% vs.14.7%, p = 0.057), while locoregional recurrence was similar (7.7% vs. 7.4%). IC was associated with significantly improved survivals with the 5-year RFS and OS rates for the IC group of 85.1% and 90.5%, respectively, compared to of 46.2% and 48.1% for the non-IC group (p = 0.008 for RFS, and p = 0.015 for OS). By multivariable analyses, IC remained the only significant factor associated with survivals (HR:0.18 for RFS, p = 0.020 and HR:0.18 for OS, p = 0.025). The effect of IC in the whole cohort, irrespective of pathological response, was also assessed. Patients with non-pCR in the IC group had a trend toward worse survivals compared to the non-IC group Conclusions In ESCC patients with pCR after trimodality treatment, IC was associated with favorable survivals. The benefits of IC might be a hypothesis generation for adjuvant treatment for patients with pCR.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
妖孽宇发布了新的文献求助10
1秒前
aa完成签到,获得积分20
1秒前
aaaa完成签到,获得积分10
1秒前
马香芦完成签到,获得积分10
2秒前
西红柿完成签到,获得积分10
3秒前
4秒前
懵懂的冬灵完成签到,获得积分10
4秒前
碧蓝可仁完成签到 ,获得积分10
5秒前
王拉拉完成签到 ,获得积分10
5秒前
西西完成签到,获得积分10
5秒前
深情安青应助mkmimii采纳,获得10
6秒前
上官若男应助小王采纳,获得10
6秒前
bkagyin应助旦皋采纳,获得10
6秒前
Orange应助欣欣采纳,获得10
7秒前
玄学大哥完成签到,获得积分10
7秒前
7秒前
7秒前
kk完成签到,获得积分10
7秒前
ww007完成签到,获得积分10
9秒前
科研通AI5应助hahaha123213123采纳,获得10
9秒前
misstwo完成签到,获得积分10
10秒前
研友_ZzrwqZ发布了新的文献求助10
10秒前
JY'完成签到,获得积分10
11秒前
一只小鲨鱼完成签到,获得积分10
12秒前
漂亮的哈密瓜完成签到,获得积分10
12秒前
量子星尘发布了新的文献求助10
12秒前
13秒前
LL发布了新的文献求助10
13秒前
苏苏完成签到,获得积分10
14秒前
14秒前
fabc5653219完成签到,获得积分10
15秒前
hkunyu完成签到 ,获得积分10
15秒前
jiao完成签到,获得积分10
16秒前
16秒前
LIUYONG完成签到,获得积分10
17秒前
ChatGPT发布了新的文献求助10
18秒前
18秒前
小王发布了新的文献求助10
18秒前
这个大头张呀完成签到,获得积分10
18秒前
19秒前
高分求助中
【提示信息,请勿应助】关于scihub 10000
Les Mantodea de Guyane: Insecta, Polyneoptera [The Mantids of French Guiana] 3000
徐淮辽南地区新元古代叠层石及生物地层 3000
The Mother of All Tableaux: Order, Equivalence, and Geometry in the Large-scale Structure of Optimality Theory 3000
Global Eyelash Assessment scale (GEA) 1000
Picture Books with Same-sex Parented Families: Unintentional Censorship 550
Research on Disturbance Rejection Control Algorithm for Aerial Operation Robots 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 4038388
求助须知:如何正确求助?哪些是违规求助? 3576106
关于积分的说明 11374447
捐赠科研通 3305798
什么是DOI,文献DOI怎么找? 1819322
邀请新用户注册赠送积分活动 892672
科研通“疑难数据库(出版商)”最低求助积分说明 815029